【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Cytoxan
04.1.2 Vidaza
04.1.3 Dacogen
04.1.4 Idamycin PFS
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.2 Etiology and Risk Factors
07.3 Pathophysiology
07.4 Epidemiology
07.5 Classification
07.5.1 FAB Classification
07.5.2 WHO Classification
07.6 Diagnosis
07.6.1 Blood Samples
07.6.2 Bone Marrow Samples
07.6.3 Spinal Fluid
07.6.4 CBC and Peripheral Smear
07.6.5 Blood Chemistry and Coagulation Tests
07.6.6 Microscopic Exams
07.6.7 Cytochemistry
07.6.8 Flow Cytometry and Immunohistochemistry
07.6.9 Cytogenetics
07.6.10 FISH and PCR
07.6.11 X-Ray
07.6.12 CT Scan
07.6.13 Ultrasound
07.6.14 MRI Scan
07.7 Treatment and Management
07.7.1 Induction Therapy
07.7.2 Post Remission Therapy
07.8 Economic Burden
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Class of Drugs
09.1 Alkylating Agent
09.2 Cytotoxic Antibiotic
09.3 Topoisomerase Inhibitor
09.4 Others
10.Geographical Segmentation
11.Buying Criteria
12.Market Growth Drivers
13.Drivers and their Impact
14.Market Challenges
15.Impact of Drivers and Challenges
16.Market Trends
17.Trends and their Impact
18.Pipeline Portfolio
19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Celgene
19.2.2 Johnson & Johnson
19.2.3 Pfizer
19.2.4 Bristol Myers Squibb
19.3 Other and Future Prominent Vendors
20.Key Vendor Analysis
20.1 Bristol Myers Squibb
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Revenue by Business Segmentation
20.1.5 Revenue Comparison 2013 and 2014
20.1.6 Sales by Geography
20.1.7 Business Strategy
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Celgene
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Revenue by Business Segmentation
20.2.5 Revenue Comparison 2013 and 2014
20.2.6 Sales by Geography
20.2.7 Business Strategy
20.2.8 Key Developments
20.2.9 SWOT Analysis
20.3 Johnson and Johnson
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Revenue by Business Segmentation
20.3.5 Revenue Comparison 2013 and 2014
20.3.6 Sales by Geography
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Pfizer
20.4.1 Key Facts
20.4.2 Business Description
20.4.3 Business Segmentation
20.4.4 Revenue by Business Segmentation
20.4.5 Revenue Comparison 2013 and 2014
20.4.6 Sales by Geography
20.4.7 Business Strategy
20.4.8 Key Developments
20.4.9 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot of Acute Myeloid Leukemia
Exhibit 3: Percentage of Acute Myeloid Leukemia Cases in Comparison with Other Types of Leukemia in the US 2014
Exhibit 4: FAB Classification of Acute Myeloid Leukemia
Exhibit 5: FAB Classification of Acute Myeloid Leukemia and the Percentage of Patients in Each Class
Exhibit 6: Percentage Distribution of Acute Myeloid Leukemia Patients According to the FAB Classification
Exhibit 7: The WHO Classification of Acute Myeloid Leukemia
Exhibit 8: Treatment Options for Acute Myeloid Leukemia
Exhibit 9: Treatment Options for Relapsed Acute Myeloid Leukemia
Exhibit 10: Snapshot of the Economic Burden of Acute Myeloid Leukemia
Exhibit 11: Cost Per Patient in Different Treatment Cycles in the US (2012)
Exhibit 12: Cost Per Patient in Different Treatment Cycles in the UK (2012)
Exhibit 13: Snapshot of the Global Acute Myeloid Leukemia Therapeutics Market, 2014
Exhibit 14: Global Acute Myeloid Leukemia Therapeutics Market 2014-2019 (US$ million)
Exhibit 15: Global Acute Myeloid Leukemia Therapeutics Market Segmentation by Class of Drugs
Exhibit 16: Global Acute Myeloid Leukemia Therapeutics Market Segmentation by Class of Drugs 2014
Exhibit 17: Global Acute Myeloid Leukemia Therapeutics Market by Geographical Segmentation 2014
Exhibit 18: Buying Criteria of Global Acute Myeloid Leukemia Therapeutics Market
Exhibit 19: Phase III Pipeline Molecules for Acute Myeloid Leukemia
Exhibit 20: Global Acute Myeloid Leukemia Therapeutics Market Share Analysis 2014
Exhibit 21: Authorization Details of Vidaza
Exhibit 22: Regulatory History of Dacogen
Exhibit 23: Authorization Details of Dacogen
Exhibit 24: Bristol-Myers Squibb: Business Segmentation 2014
Exhibit 25: Bristol-Myers Squibb: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 26: Bristol-Myers Squibb: Sales by Geography (in US$ million)
Exhibit 27: Celgene: Business Segmentation by Revenue 2013 and 2014
Exhibit 28: Celgene: Sales by Geography 2014 (Pharmaceuticals Division)
Exhibit 29: Celgene: Sales by Geography 2014 (Diagnostics Division)
Exhibit 30: Johnson & Johnson: Business Segmentation by Revenue 2014
Exhibit 31: Johnson & Johnson: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 32: Johnson & Johnson: Sales by Geography 2014
Exhibit 33: Pfizer: Business Segmentation
Exhibit 19: Pfizer: Revenue by Business Segmentation 2014
Exhibit 20: Pfizer: Revenue by Business Segmentation 2013 and 2014 (US$ million)
Exhibit 21: Pfizer: Revenue by Geographical Segmentation 2014
【レポート販売概要】
■ タイトル：急性骨髄性白血病（AML）治療薬の世界市場2015-2019■ 英文：Global Acute Myeloid Leukemia Therapeutics Market 2015-2019
■ 発行日：2014年12月24日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4899
■ 調査対象地域：グローバル
- クラウドストレージゲートウェイの世界市場2016-2020About Cloud Storage Gateway Cloud storage gateways are hybrid appliances that combine local storage, data protection functionality, and cloud storage to form a collaborative, cost-effective package. A storage gateway ensures compatibility between different protocols used by cloud service providers and enterprises. In addition, it provides seamless connectivity between a local system and a cloud st …
- 商用航空機MRO(保守・修理・点検)の世界市場2019-2023119 pages, November 2018 About this market The advent of IoT enabled jet engines is likely to drive growth in the market. IoT is an emerging concept that facilitates many connected things to collect and share data about usage patterns and the work environment, thereby forming a network between unanimated objects and their users. Technavio’s analysts have predicted that the commercial aircraft MRO …
- 抗菌性包装の世界市場2016-2020：抗菌性プラスチック包装、抗菌性バイオポリマー包装、抗菌性板紙包装About Antimicrobial Packaging Antimicrobial packaging is an active technology packaging solution. Antimicrobial agents are active barrier agents that are added to packaging materials for making antimicrobial packaging materials. Antimicrobial packaging materials are used to prevent the penetration of small atmospheric and molecular gases, such as carbon dioxide, oxygen, volatile flavor nitrogen co …
- PharmaFocus: HIV – R&D Strategies towards Cure and PreventionPharmaFocus: HIV - R&D Strategies towards Cure and Prevention Summary It has been 30 years since the discovery that HIV is the causative agent of AIDS, and yet no preventative vaccine or cure that allows independence from lifelong antiretroviral treatment exists. Despite some recent setbacks, such as the discontinuation of the HVTN 505 clinical trial due to a trend of increased infection, there ha …
- 神経生理学用針および電極の世界市場2016-2020About Neurophysiology Needles and Electrodes Neurophysiology needles and electrodes help convert ionic energy to electric current in the body and amplify the electric current for the diagnosis and treatment of diseases. These needles and electrodes also help record the brain and nerve activity during EEG and EMG. These procedures help diagnose neurological diseases such as epilepsy, amyotrophic la …
- 医療用複合材料の世界市場予測：炭素繊維、セラミック繊維、ガラス繊維The global medical composites market is projected to grow from USD 663.3 Million in 2016 to USD 934.7 Million by 2021, at a CAGR of 7.10% during the forecast period. The medical composites market is growing because of high demand for diagnostic imaging application as they are radiolucent and do not hinder the diagnosis process. Medical composites manufactured using carbon fiber has advantages such …
- 持続的腎代替療法 (CRRT)の世界市場On the basis of products, the continuous renal replacement therapy market is classified into CRRT systems, CRRT disposables, and dialysate and replacements fluids. The CRRT disposables segment is further divided into hemofilters, bloodlines, and other disposables. The CRRT dialysate and replacement fluids segment is expected to account for the largest share of the global market in 2015. This high …
- 教育用電子機器の世界市場：デスクトップ、ノートPC、タブレットPC、プロジェクター、サウンド・システム、電子黒板About Education Hardware Digitization of education has resulted in trends such as online learning and open education, which emphasize the strong role of technology in the education sector. Growing competition has led to a rise in the standards of education. As a result, educational institutions have adopted digital learning and are using desktops, projectors, and sound systems to enhance the learn …
- 世界の大動脈ステント移植片市場（2014-2018）About Aortic Stent Grafts An aortic stent graft is a stainless steel metal mesh-like tube composed of woven polyester fabric. Stent grafts are categorized on the basis of product application type into two three segments: Abdominal Aortic Stent Grafts, Thoracic Aortic Stent Grafts and Fenestrated Aortic Stent Grafts. Bifurcated and Aorta-uni-iliac. Aortic stent grafts are used for a variety of cond …
- Machine-to-Machine (M2M) and RFIDMachine-to-Machine (M2M) communications and Radio Frequency ID (RFID) together represent a means of direct communication between connection hardware and the object that needs monitoring: the information about its status of performance is directly sent to a computer system without the need for human intervention. This makes automation of processes or consumer action possible. The technology that ut …
- 産業用エネルギー管理システムの世界市場：エネルギー管理ソフトウェア/装置/サービスAbout Energy Management System in Industrial Sector Energy management system for the Industrial sector is a system of computer-aided tools that help industries to monitor, control, and optimize their electrical loads. Energy management trend is shifting from hardware-based solutions to extensive software, hardware, and service-based solutions. This is achieved through a holistic view into the ener …
- 農業用乾燥機の世界市場2017-2021About Industrial DryersFood drying is a method to preserve food by desiccating or dehydrating the food products. Drying inhibits the growth of yeasts, bacteria, and mold. A dryer is a device used to dry foods including a set of specific agricultural products like fruits, vegetables, nuts, herbs, and phytopharmaceutical products. The market includes industrial dryers based on different heating mech …
- 炭素繊維強化プラスチック（CFRP）の世界市場2016-2020About Carbon Fiber-Reinforced PlasticCFRPs are high-strength and lightweight composite materials that contain a matrix, which is generally a polymer resin, and carbon fiber, a reinforcement material. Epoxy is the most commonly used polymer resin for manufacturing CFRPs. However, other polymers such as polyester, vinyl ester, or nylon are also used as reinforcement matrices. The properties of these …
- 固形腫瘍治療薬の世界市場2016-2020About the Solid Tumors Drugs Market The rising prevalence of various cancers, which has led to innovations and technological advancements, drives the development of new immunotherapy drugs that are more effective than the available drugs to treat solid tumors. Solid tumors are an abnormal mass of tissue that do not contain cysts or liquid areas. These may be malignant (cancerous) or benign (not ca …
- 世界の熱伝導材料市場2015The Global Thermal Interface Material Industry Report 2015 is a professional and in-depth study on the current state of the Thermal Interface Material industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Thermal Interface Material market analysis is provided for the international markets including devel …
